Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Monday, October 26, 2015

CME event: "Clinical Challenges in MS Care: Family Planning, Pregnancy, and Disease-Modifying Therapies"


MS leaders e-mail logo header 

Dear Colleague,

Can you correctly answer this question:

The FDA definition of 'Pregnancy Category C' includes all of the following, EXCEPT for:
  
A. Animal studies have shown an adverse effect on the fetus

B. Potential benefits may warrant use of the drug in pregnant women despite potential risks

C. There are no adequate and well-controlled studies in pregnant women

D. Adequate, well-controlled studies in pregnant women have not shown an increased risk of fetal abnormalities to the fetus in any trimester of pregnancy

Participate in this John Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing educational activity to learn the answer to this and other questions related to MS therapy in women of childbearing age.


EARN CME or CNE Credit!

The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing, in cooperation with Medical Logix, LLC, are currently offering this educational program certified for CME and CNE credit, at no charge to participants:


 Video Clinical Dialogue and eCase Challenge:



Jointly presented by the Johns Hopkins University School of Medicine and the 
Institute for Johns Hopkins Nursing

These activities have been approved for AMA PRA Category 1 CreditTM
and contact hours for nurses. There are no fees or prerequisites.

Please keep in mind that you will need to login with your email address and password to access this program. If you forgot your password, click on the "Forgot Password" link in the top right corner of the site.

We hope you enjoy this informative educational program!

The MS-Leaders Team

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

To view the activity, please CLICK HERE 

The Johns Hopkins University School of Medicine Office of Continuing Medical  Education, Turner 20, 720 Rutland Ave, Baltimore, MD 21205

In cooperation with Medical Logix, LLC

Medical Logix, LLC, 130 W. Main Street, Suite 144, Collegeville, PA 19426


Please do not respond to this email directly.
Any questions or concerns,  email: support@ms-leaders.org 

  


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here
.===================================

No comments: